Clinical trial
Cohort of Liver Transplanted Patients With Hepatitis C Virus Recurrence and Treated With Direct-acting Antiviral Agents
NCT01944527 is registered in ClinicalTrials.gov with ANRS, Emerging Infectious Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cohort of Liver Transplanted Patients With Hepatitis C Virus Recurrence and Treated With Direct-acting Antiviral Agents
- Lead sponsor
- ANRS, Emerging Infectious Diseases
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 31, 2013
- Completion date
- June 30, 2017
- Enrollment
- 699 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
direct-acting antiviral agents, hcv recurrence, liver transplantation